iSelect Fund
  • Portfolio
  • Team
    • Team
    • Selection Committee
    • Portfolio Company CEOs
  • Focus Areas
    • Food & Agriculture
    • Healthcare
    • Soil Health
    • Impact Investing
    • Entrepreneurs
  • Invest
  • Content
    • Blog
    • Videos
    • Agrifood Conversations
    • FAQ
  • Contact
    • Log In
    • Register
    • My iSelect
Select Page

Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM

CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions Source: Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay,... Read more

Related Posts

  • changes in Agriculture
    Dr. Todd Mockler on Plant Science, Genomics, and the Future of Food
  • Gene Editing
    Don’t Worry Dad, We Are Just Editing Our Genes  
  • DNA
    Cofactor Genomics: RNA Is About to Make Personalized Medicine a Reality
  • Cofactor Genomics
    [PODCAST] Cofactor Genomics and the Future of Personalized Medicine
  • iSelect
    iSelect Monthly Update: January 2018

Our Networks

Food & Agriculture
Healthcare

(314) 219-8688

1401 S. Brentwood Blvd.
Suite 300
St. Louis, MO 63144

Crunchbase   Medium   Twitter   LinkedIn   Facebook   YouTube

Investments in private offerings are speculative, illiquid and involve a high degree of risk. It is not unusual for an investor in a private offering to lose the entire amount of the investment. Investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results. Securities are offered through North Capital Private Securities, member FINRA/SIPC. All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity. All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in futures or other investments. North Capital Inc. is a Registered Investment Advisor and Commodities Trading Advisor. North Capital Private Securities Corporation is a registered broker dealer, member FINRA | SIPC.

The relationship between North Capital Investment Technology, North Capital Inc., and North Capital Private Securities Corporation is described in our Disclosure Documents and Code of Ethics. Check the background of this firm on FINRA's BrokerCheck © 1999-2020. All Rights Reserved. Submit a Complaint

©2020 iSelect Fund | Your use of this website signifies that you accept iSelect’s website terms and conditions of use and privacy policy.